Media stories about Cutera (NASDAQ:CUTR) have been trending somewhat positive this week, AlphaOne Sentiment reports. AlphaOne, a unit of Accern, identifies positive and negative news coverage by reviewing more than twenty million blog and news sources in real time. AlphaOne ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Cutera earned a daily sentiment score of 0.13 on AlphaOne’s scale. AlphaOne also gave news coverage about the medical device company an impact score of 89 out of 100, indicating that recent news coverage is very likely to have an effect on the company’s share price in the near future.
CUTR has been the topic of several research reports. Zacks Investment Research upgraded shares of Cutera from a “hold” rating to a “buy” rating and set a $21.00 price target on the stock in a research report on Monday, January 23rd. TheStreet cut shares of Cutera from a “b-” rating to a “c” rating in a research report on Monday, May 1st. Finally, Sidoti started coverage on shares of Cutera in a research report on Tuesday, April 11th. They issued a “buy” rating and a $27.00 price target on the stock.
Cutera (NASDAQ:CUTR) opened at 20.20 on Friday. The firm’s 50-day moving average is $20.13 and its 200-day moving average is $18.59. The company has a market cap of $279.93 million, a PE ratio of 77.39 and a beta of 0.88. Cutera has a 52-week low of $9.99 and a 52-week high of $22.96.
Cutera (NASDAQ:CUTR) last released its earnings results on Monday, May 1st. The medical device company reported ($0.07) EPS for the quarter, hitting analysts’ consensus estimates of ($0.07). Cutera had a return on equity of 8.59% and a net margin of 2.18%. The company had revenue of $29.30 million for the quarter, compared to the consensus estimate of $29 million. During the same quarter last year, the business posted ($0.16) EPS. Cutera’s quarterly revenue was up 30.8% compared to the same quarter last year. On average, equities research analysts anticipate that Cutera will post $0.48 EPS for the current year.
In other Cutera news, EVP Larry Laber sold 1,500 shares of the stock in a transaction that occurred on Tuesday, February 21st. The stock was sold at an average price of $21.97, for a total transaction of $32,955.00. Following the transaction, the executive vice president now owns 72,665 shares of the company’s stock, valued at approximately $1,596,450.05. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, EVP Miguel Pardos sold 5,000 shares of the stock in a transaction that occurred on Thursday, April 20th. The stock was sold at an average price of $21.00, for a total value of $105,000.00. Following the transaction, the executive vice president now directly owns 44,698 shares in the company, valued at approximately $938,658. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 382,347 shares of company stock worth $7,734,028. 11.60% of the stock is currently owned by company insiders.
TRADEMARK VIOLATION WARNING: “Somewhat Favorable Press Coverage Very Likely to Affect Cutera (CUTR) Stock Price” was posted by Sports Perspectives and is the sole property of of Sports Perspectives. If you are reading this piece of content on another site, it was stolen and reposted in violation of United States and international copyright & trademark law. The original version of this piece of content can be accessed at https://sportsperspectives.com/2017/05/20/cutera-cutr-given-daily-news-sentiment-score-of-0-13-updated-updated.html.
Cutera, Inc is a medical device company. The Company is engaged in the design, development, manufacture, marketing and servicing of laser and other energy-based aesthetics systems for practitioners across the world. The Company offers products based on product platforms, such as enlighten, excel HR, truSculpt, excel V and xeo, each of which enables physicians and other practitioners to perform aesthetic procedures for customers.
Receive News & Ratings for Cutera Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera Inc. and related companies with MarketBeat.com's FREE daily email newsletter.